Home/Hedge Fund Intelligence/Crescent Biopharma, Inc.
Nasdaq: CBIOStockForm 13F30 Jun 2026

Hedge funds that hold Crescent Biopharma, Inc. Nasdaq: CBIO

CUSIP G2545C104 · who reports it, how much, and how much it matters to them

15 of the 720 hedge fund managers we track reported shares of Crescent Biopharma, Inc. (Nasdaq: CBIO) on Form 13F for 30 June 2026. Between them they reported USD 149m. The largest position belongs to Fairmount Funds Management, at USD 49m.

Managers reporting it15of 720 we track
Value they reportUSD 149mshares only, 30 Jun 2026
Funds they run210with a file on PPLI.com
Largest positionUSD 49mFairmount Funds Management
Typical weight0.0%median share of a manager's book
Heaviest weight3.3%Fairmount Funds Management

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

15 managers, USD 149m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Crescent Biopharma, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Fairmount Funds Management2 funds on PPLI.comUSD 49m3.3%
2Logos Global Management1 fund on PPLI.comUSD 34m1.5%
3Balyasny Asset Management25 funds on PPLI.comUSD 30m0.0%
4Millennium Management6 funds on PPLI.comUSD 7.3m0.0%
5RTW Investments2 funds on PPLI.comUSD 6.7m0.1%
6POINT72 Asset Management17 funds on PPLI.comUSD 5.4m0.0%
7Marshall Wace LLP84 funds on PPLI.comUSD 3.9m0.0%
8Perceptive Advisors6 funds on PPLI.comUSD 3.7m0.1%
9Two Sigma Investments35 funds on PPLI.comUSD 3.4m0.0%
10Exome Asset Management2 funds on PPLI.comUSD 2.3m1.4%
11Burkehill Global Management5 funds on PPLI.comUSD 1.3m0.0%
12Moore Capital Management7 funds on PPLI.comUSD 450,0000.0%
13Squarepoint Ops7 funds on PPLI.comUSD 435,0000.0%
14Persistent Asset Partners10 funds on PPLI.comUSD 197,0000.1%
15The Quarry1 fund on PPLI.comUSD 5220.0%
Next: where it matters most
Where it matters most

For Fairmount Funds Management it is 3.3% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Fairmount Funds ManagementUSD 49m3.3%
2Logos Global ManagementUSD 34m1.5%
3Exome Asset ManagementUSD 2.3m1.4%
4Persistent Asset PartnersUSD 197,0000.1%
5RTW InvestmentsUSD 6.7m0.1%
6Perceptive AdvisorsUSD 3.7m0.1%
7Burkehill Global ManagementUSD 1.3m0.0%
8Balyasny Asset ManagementUSD 30m0.0%
9Moore Capital ManagementUSD 450,0000.0%
10POINT72 Asset ManagementUSD 5.4m0.0%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Crescent Biopharma, Inc.

What is the ticker symbol of Crescent Biopharma, Inc.?

Crescent Biopharma, Inc. trades under the symbol CBIO on the Nasdaq. Its CUSIP, the code used on Form 13F, is G2545C104.

Which hedge funds own Crescent Biopharma, Inc. (Nasdaq: CBIO)?

15 of the 720 hedge fund managers PPLI.com tracks reported Crescent Biopharma, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Fairmount Funds Management (USD 49m), Logos Global Management (USD 34m), Balyasny Asset Management (USD 30m), Millennium Management (USD 7.3m) and RTW Investments (USD 6.7m).

How many hedge funds hold Crescent Biopharma, Inc.?

15 managers in our coverage reported it, and between them they run 210 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Crescent Biopharma, Inc.?

Fairmount Funds Management, where the position was 3.3% of the reported 13F book at 30 June 2026.

Does this show who is short Crescent Biopharma, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Crescent Biopharma, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.